Skip to content

    Recently Viewed

      Listening...

      johnson-and-johnson-named-to-fortunes-2023-americas-most-innovative-companies-list-0323.jpg

      Johnson & Johnson named to Fortune‘s 2023 America’s Most Innovative Companies list

      The company has been recognized on the inaugural list for its innovative spirit—a trait that’s been at the heart of Johnson & Johnson’s mission to improve health for people across the globe for over a century.

      Share Article
      share to

      What do groundbreaking healthcare advances, a vibrant company mindset and an unwavering commitment to fostering new and creative ideas have in common?

      They are all rooted in innovation.

      Since its founding in 1886, innovation has been one of Johnson & Johnson’s core tenets, highlighted in Our Credo, the company’s guiding mission statement.

      Today, the company is being honored for this dedication to innovation as it ranks in the top 20 on Fortune’s inaugural list of America’s Most Innovative Companies.

      What It Means to Be an Innovative Company

      Fortune and its partner, market research and data company Statista, reviewed more than 15,000 eligible companies to create the list. Each eligible company was measured against three pillars: product innovation, process innovation and innovation culture.

      • Product innovation encompasses product and service design and its usability and uniqueness, as well as innovations in research and development.
      • Process innovation evaluates innovation in sourcing and production, marketing, sales and support.
      • Innovation culture is measured by the extent to which a company internally fosters a spirit of entrepreneurship and creativity.
      Earlier this year, Fortune spotlighted Johnson & Johnson as one of its World’s Most Admired Companies, taking the #1 spot in the Pharmaceutical category.

      Johnson & Johnson has delivered in all three of these areas. For 137 years, innovation has fueled the work happening inside and outside company walls—including groundbreaking efforts to tackle some of the world’s toughest health challenges, new ideas to support health equity solutions, galvanizing work toward building a healthier planet and more.

      Over the years, Johnson & Johnson has been recognized for its cutting-edge approach to advancing healthcare and empowering patients. In 2022, Johnson & Johnson MedTech (JJMT) was selected as one of Fast Company’s Most Innovative Companies in its Health category. Earlier this year Fortune also spotlighted Johnson & Johnson as one of its World’s Most Admired Companies, taking the #1 spot in the Pharmaceutical category.

      Johnson & Johnson is honored to be named as one of America’s Most Innovative Companies by Fortune.

      When you’ve been innovating for over 135 years …

      Johnson & Johnson has a virtual museum where you can learn more fun facts about its rich history.

      More from Johnson & Johnson

      Innovation
      A female scientist conducting research in a laboratory, focusing on orphan drugs for rare diseases

      What is an orphan drug?

      The need for these rare disease therapies is strong, and access to them can be lifesaving. Here’s how Johnson & Johnson is innovating to help give patients options.
      Caring & giving
      Sam Seavey piloting an aircraft from the cockpit

      3 health advocates; 1 Johnson & Johnson program that offers empowerment and connection

      In the quest to solve the toughest health challenges, innovating therapies and finding treatments are essential—but so is supporting the patients living with these diseases. That’s exactly why Johnson & Johnson launched HealtheVoices a decade ago.
      Innovation
      Two cardiac electrophysiologists performing a cardiac ablation procedure to treat AFib

      What is cardiac ablation?

      For American Heart Month, learn how Johnson & Johnson is innovating to help treat the millions of people who are living with atrial fibrillation and other conditions that cause an irregular heartbeat.
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.